| 发明名称 |
CORE TABLET FOR CONTROLLED RELEASE OF GLICLAZIDE AFTER ORAL ADMINISTRATION |
| 摘要 |
<p>The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the release being insensitive to variations in the pH of the dissolution medium.</p> |
| 申请公布号 |
SK10952001(A3) |
申请公布日期 |
2001.12.03 |
| 申请号 |
SK20010001095 |
申请日期 |
1999.10.15 |
| 申请人 |
ADIR ET COMPAGNIE |
发明人 |
HUET DE BAROCHEZ BRUNO;WUTHRICH PATRICK;MARTIN LOUIS |
| 分类号 |
A61K9/20;A61K9/22;A61K9/26;A61K31/403;A61K31/64;A61K47/26;A61K47/38;A61P3/10;A61P5/00;(IPC1-7):A61K9/20 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
